Prevention and Treatment of Patient Before, During, and After Covid-19 Infection
Condition: Covid19
MeSH terms: COVID-19
Study type: Interventional
Phase: Phase 2

Summary: 
      AntiCov-220 prevents and treats before, during, and after infection with SARS-Cov-2. The
      composition is fractionally extracted from herbs, using flavonoids, isoflavonoids, and
      pregnenolone in combination with ascorbic acid as the key compounds in preventing and killing
      SARS-CoV-2; increase antibodies and protect cells; supplementing precursors to help the body
      strengthen antibodies and reduce the risk of infection; destroy spike protein, toxic protein,
      help prevent blood clots causing stroke; restore the physiological function of cells after
      virus infection; helps the body to stabilize the amount of cortisol in the blood as well as
      stabilize the production of specific antibodies. The composition participates in
      anti-inflammatory and cells protecting process, bringing blood cortisol, B-lymphocytes, Cyfra
      21-1, WBC, CRP, fever, dyspnea, and other signs of respiratory tract inflammation to a normal
      state and normal limit.
    

Detailed description: 
      AntiCov-220 can eliminate COVID-19 and its variants at a very early stage when they have not
      had enough time to multiply and cause disease. AntiCov-220 contains precursors, flavonoids,
      special enzymes responsible for protecting human cell membranes and destroying cell membranes
      of some viruses, especially, COVID-19 cannot replicate in the presence of AntiCov-220 in the
      body.

      AntiCov-220 contains precursors of cortisol. As the investigators know, cortisol has a cell
      anti-inflammatory, blood pressure regulation, blood sugar regulation, energy booster, and
      anti-stress role. It provides precursors to help direct and balance the amount of cortisol in
      the body that has been imbalanced before.

      AntiCov-220 contains flavonoids and Isoflavonoids that are cytoprotective antioxidants,
      clinically proven to destroy SARS-CoV-2, HBV, HIV, HCV, viruses, reduce complications after
      COVID-19 infection, prevent neurological sequelae, stroke, cardiovascular sequelae,
      respiratory sequelae, ...

      The anti-inflammatory, stress-reducing, cell-protective, anti-viral, and immunosuppressive
      process are performed by an in vivo method that has proven its effectiveness more than ten
      years ago. AntiCov-220 is an innovative product that can fight against COVID-19 and its
      variants in the current epidemic situation.

      AntiCov-220 is committed to protecting the community of people infected with HBV, HIV, HCV,
      SARS-CoV-2 against the risk of the COVID-19 pandemic and its mutations.

      AntiCov-220 easy to implement, highly effective, and helps reduce public health costs, which
      is essential in protecting human health.

      AntiCov-220 can be used alongside with current standard treatment regimens prescribed by the
      World Health Organization.
    

Intervention name(s): AntiCov-220 (1); AntiCov-220 (2)
Intervention type(s): Drug; Drug
Intervention description(s): The daily maintenance, AntiCov-220 (1) dose is to take 3 times a day, 1 tablet each time.; The daily maintenance, AntiCov-220 (2) dose is to take 3 times a day, 1 tablet each time.
Allocation: Non-Randomized
Intervention model: Parallel Assignment
Masking: Single (Participant)
Primary purpose: Treatment
Keywords: AIDS; HIV; HBV; HCV; Stroke; Metabolic dissorder; Stress